Study the prevalence of rifampicin resistance among pulmonary tuberculosis patients by genexpert assay from a tertiary care hospital of North India.

Jitendra Chandra DevrariMadhu Chauhan

Published in: International journal of mycobacteriology (2023)

The rate of RIF-RR was found 3.2% of total samples which was more in males. The overall positivity rate was 20%, and the rate of positivity decreased from 32% to 14% over the 4 years in sputum samples. Hence, the GeneXpert assay was found to be very important tool to detect RIF-RR among suspected PTB patients.

Keyphrases

pulmonary tuberculosis
end stage renal disease
mycobacterium tuberculosis
newly diagnosed
peritoneal dialysis
prognostic factors
cystic fibrosis
high throughput
patient reported outcomes